Advertisement
Advertisement
ANGO
AngioDynamics, Inc.
11.73
USDSponsored
-0.08
-0.69%
Nov 06, 11:55 UTC -5
Open
AngioDynamics, Inc. (ANGO) Earnings
ANGO Earnings Reports
Positive Surprise Ratio
ANGO beat 31 of 43 last estimates.
72%
Next Report
Date of Next Report
Jan 04, 2027
Estimate for Q2 27 (Revenue/ EPS)
$85.88M
/-$0.06
Implied change from Q1 27 (Revenue/ EPS)
+6.14%
/+50.00%
Implied change from Q2 26 (Revenue/ EPS)
+8.12%
/--
AngioDynamics, Inc. earnings per share and revenue
On Oct 08, 2026, ANGO reported earnings of -0.04 USD per share (EPS) for Q1 27, beating the estimate of -0.11 USD, resulting in a 65.40% surprise. Revenue reached 80.92 million, compared to an expected 82.11 million, with a -1.46% difference. The market reacted with a -20.86% price change (close before vs. close after earnings).
Looking ahead to Q2 27, -- analysts forecast an EPS of -0.06 USD, with revenue projected to reach 85.88 million USD, implying an increase of 50.00% EPS, and increase of 6.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
FAQ
What were AngioDynamics, Inc.'s earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, AngioDynamics, Inc. reported EPS of -$0.04, beating estimates by 65.4%, and revenue of $80.92M, -1.46% below expectations.
How did the market react to AngioDynamics, Inc.'s Q1 2027 earnings?
The stock price moved down -20.86%, changed from $14.19 before the earnings release to $11.23 the day after.
When is AngioDynamics, Inc. expected to report next?
The next earning report is scheduled for Jan 04, 2027.
What are the forecasts for AngioDynamics, Inc.'s next earnings report?
Based on --
analysts, AngioDynamics, Inc. is expected to report EPS of -$0.06 and revenue of $85.88M for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.